FDA Grants AP Status for Carbamazepine ANDA219072 by Yichang Humanwell
The FDA has granted approval status (AP) for the ANDA219072 application for Carbamazepine submitted by Yichang Humanwell.
Asset / Drug
Drug and asset intelligence for Carbamazepine with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.